The Business Times

Pharma firm Anges and Osaka University to begin testing coronavirus vaccine on animals

Published Tue, Mar 24, 2020 · 12:53 AM

[TOKYO] Japanese biopharmaceutical firm Anges Inc said on Tuesday it and partner Osaka University had completed development of a prophylactic DNA vaccine against the new coronavirus and that it would begin testing it in animals soon.

Shares of Anges were untraded with a glut of buy orders in early morning.

There are now more than 350,000 cases of coronavirus infections globally and over 15,000 deaths resulting from the disease it causes, called Covid-19.

REUTERS

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here